C M Balch, A C Buzaid. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/therapeutic useClinical Trials as TopicDisease-Free SurvivalHumansInterferon Type I/therapeutic useLymphatic MetastasisMelanoma/mortalityMelanoma/pathologyMelanoma/secondaryMelanoma/therapyNeoplasm Recurrence, Local/therapyPrognosisRecombinant ProteinsSkin Neoplasms/mortalitySkin Neoplasms/pathologySkin Neoplasms/therapySurvival Rate
Substances： See more » Antineoplastic AgentsInterferon Type IRecombinant Proteins
Year: 1996 PMID： 8558183 DOI： 10.1200/JCO.1996.14.1.1
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544